These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2170907)

  • 41. [Desferrioxamine-B in the diagnosis of hemosiderotic states and in the therapy of thalassemia. Apropos of 2 cases].
    De Luca G; Faelli U; Petrussa I
    Minerva Pediatr; 1966 Oct; 18(32):1920-5. PubMed ID: 5993655
    [No Abstract]   [Full Text] [Related]  

  • 42. Current treatment of Cooley's anemia. Intravenous chelation therapy.
    Cohen AR; Martin M; Schwartz E
    Ann N Y Acad Sci; 1990; 612():286-92. PubMed ID: 2291556
    [No Abstract]   [Full Text] [Related]  

  • 43. Yersinia pseudotuberculosis septicaemia in thalassaemia major.
    Gordts B; Rummens E; deMeirleir L; Butzler JP
    Lancet; 1984 Jan; 1(8367):41-2. PubMed ID: 6140358
    [No Abstract]   [Full Text] [Related]  

  • 44. [Antithrombin III and congenital hemolytic anemia].
    Giustolisi R; Musso R; Cacciola E
    Haematologica; 1990; 75 Suppl 2():54-63. PubMed ID: 2387552
    [No Abstract]   [Full Text] [Related]  

  • 45. [Septicemia caused by Yersinia enterocolitica. General review apropos of a new case in a young women presenting with thalassemia major].
    Roche G; Leheup B; Gérard A; Canton P; Lion C; Leichtmann G; Dureux JB
    Rev Med Interne; 1982 Mar; 3(1):65-74. PubMed ID: 7048474
    [No Abstract]   [Full Text] [Related]  

  • 46. Yersinia enterocolitica infection in patients with iron overload.
    Cianciulli P; Trua G; Papa G
    Haematologica; 1990; 75(2):197-8. PubMed ID: 2358213
    [No Abstract]   [Full Text] [Related]  

  • 47. Nontransferrin-bound serum iron in thalassemia and sickle cell patients.
    Ahmed NK; Hanna M; Wang W
    Int J Biochem; 1986; 18(10):953-6. PubMed ID: 3792614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. alpha-Thalassemia and HbF concentration in sickle cell anemia.
    Rucknagel D; Ferrucci S; Whitten CF; Sarniak I; Odenheimer D; Sing C; Bruzdzinski C
    Prog Clin Biol Res; 1984; 165():103-20. PubMed ID: 6209727
    [No Abstract]   [Full Text] [Related]  

  • 49. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Severe Yersinia enterocolitica infections in kidney failure patients under dialysis].
    Cabanne JF; Dubot P
    Presse Med; 1991 Nov; 20(38):1905. PubMed ID: 1836634
    [No Abstract]   [Full Text] [Related]  

  • 51. Alpha thalassemia changes erythrocyte heterogeneity in sickle cell disease.
    Noguchi CT; Dover GJ; Rodgers GP; Serjeant GR; Antonarakis SE; Anagnou NP; Higgs DR; Weatherall DJ; Schechter AN
    J Clin Invest; 1985 May; 75(5):1632-7. PubMed ID: 2581999
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Yersinia enterocolitica infection in thalassemia. Report of one case (author's transl)].
    Balestrazzi P; Banchini G; Menozzi MG; Frassi C; De Angelis GL; Giovannelli G
    Pediatr Med Chir; 1981; 3(4):269-71. PubMed ID: 6979742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infection due to Yersinia enterocolitica in a series of patients with beta-thalassemia: incidence and predisposing factors.
    Adamkiewicz TV; Berkovitch M; Krishnan C; Polsinelli C; Kermack D; Olivieri NF
    Clin Infect Dis; 1998 Dec; 27(6):1362-6. PubMed ID: 9868642
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Yersinia enterocolitica ileocolitis in beta-thalassemic patients.
    Greco L; Marino F; Gentile A; Catalano G; Angilletta D
    Colorectal Dis; 2006 Jul; 8(6):525. PubMed ID: 16784477
    [No Abstract]   [Full Text] [Related]  

  • 55. Iron overload and iron chelation therapy in thalassaemia and sickle cell haemoglobinopathies.
    Pippard MJ
    Acta Haematol; 1987; 78(2-3):206-11. PubMed ID: 3120473
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Infection due to Yersinia enterocolitica in healthy and chronically ill children (author's transl)].
    Strobel S; Löhr H; Posselt HG; Wönne R; Bender SW
    Dtsch Med Wochenschr; 1980 Dec; 105(50):1739-43. PubMed ID: 7439064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Multiple hepatosplenic abscesses caused by Yersinia enterocolitica in a patient with hemochromatosis].
    Zapata R; García P
    Rev Med Chil; 1997 Aug; 125(8):917-21. PubMed ID: 9567396
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological induction of fetal hemoglobin: Why haven't we been more successful in thalassemia?
    Fathallah H; Sutton M; Atweh GF
    Ann N Y Acad Sci; 2005; 1054():228-37. PubMed ID: 16339670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The 19 kDa protein of Yersinia enterocolitica O:3 is recognized on the cellular and humoral level by patients with Yersinia induced reactive arthritis.
    Appel H; Mertz A; Distler A; Sieper J; Braun J
    J Rheumatol; 1999 Sep; 26(9):1964-71. PubMed ID: 10493678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients.
    Boelaert JR; van Landuyt HW; Valcke YJ; Cantinieaux B; Lornoy WF; Vanherweghem JL; Moreillon P; Vandepitte JM
    J Infect Dis; 1987 Aug; 156(2):384-7. PubMed ID: 3598237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.